Independent guide
Compounded Semaglutide vs Wegovy
Wegovy is an FDA-approved semaglutide product; compounded semaglutide is not FDA-approved and is prepared under compounding law when applicable conditions are met.
Health information: This article is educational, not medical advice. FDA-approved branded medicines and compounded preparations are different regulatory categories. Treatment choice and prescribing require an appropriate clinician.
The key distinction
The shared active ingredient does not make the products regulatorily identical.
Wegovy has FDA-reviewed labeling, manufacturing controls and approved indications.
Practical comparison
Compounded preparations may differ in concentration, presentation and pharmacy.
Compare clinical appropriateness and access before comparing price.
Sources
- HealthRX pricing
- HealthRX FAQ
- FDA: concerns with unapproved GLP-1 drugs
- FDA: 2026 compounding policy clarification
- FDA Wegovy prescribing information
- FDA Zepbound prescribing information
Provider prices and policies can change. We date-check unstable facts and distinguish provider claims from FDA or prescribing-information sources.